Case Study

Advancing Vaccine Development

Source: QuintilesIMS

With extensive experience in vaccines development, as well as market access and commercialization strategy, Quintiles is uniquely qualified to be your ally in vaccines. With more than 20,000 talented, engaged employees in nearly 60 countries, we have provided clinical services for more than 150 vaccine trials since 2007, involving close to 300,000 patients worldwide.

Due to the efforts of Quintiles' expert vaccine trial team, study start-up and enrollment activities were completed rapidly and efficiently. Enrollment was completed in only 17 days across 2 age groups.

Interim analysis and final database lock were achieved in advance of contracted dates. High quality data was delivered early, with no critical or major findings following QA audit.

All timelines were met across all service lines, within budget, with full patient enrollment 25 days ahead of schedule.

  • Recruitment of 3,000+ subjects within a very short time frame — during the holiday season
  • Recruitment across a diverse age range, with half of subjects from an elderly population
  • Intensive monitoring, with CRA resource to perform 100% site data verification (SDV) for 3 months